Investor Supplement

Phase 1 should be read as a bounded first-node investment rather than a speculative regional rollout. The investor is underwriting one controlled Turks & Caicos operating node that combines a factory earnings floor with a measured development and land-bank overlay. The investment case is designed to make uses of capital, operating conversion, reserve logic, and investor recovery visible and governable.

The consolidated 17+5 bridge case preserves the company thesis from the earlier proof case, but expands the amplitude of Phase 1. Compared with the leaner factory-only frame, the current raise adds more early DevCo activity, a larger land position and project pipeline, and a clearer bridge into Bahamas replication logic. What does not change is the requirement that Acrete earn commercial permission through proof packs, quality systems, bounded claims, and disciplined drawdown pacing.

The bridge case sits between the lean proof case and the eventual broader platform. It is still factory-anchored and proof-first, but it is no longer a pure factory-only memo. It adds controlled development and land-bank exposure so the first operating node can generate recurring manufacturing evidence and selective monetization events.

Investors need to see a functioning operating node rather than an abstract technology program. In the current raise, the capital stack is legible: $17.0M of investor cash, $5.0M of sponsor contribution, and targeted project-level debt layered into development activity at roughly 8%, with no large platform debt.

The underwriting purpose of each bucket is important. Factory capex builds tangible productive capacity; working capital protects commissioning and early commercial rhythm; proof-system and QA spend turns claims into financeable evidence; reserve capital protects credibility in interruption-prone island execution; and development capital broadens the cash-conversion logic beyond a single revenue line.

Capital timing matters because it funds an operating model, not because it makes a spreadsheet prettier. The correct discipline in Phase 1 is sequencing: major releases should be tied to commissioning, inventory readiness, project-start milestones, reserve sufficiency, and debt-service visibility.

Phase logic only works if the revenue model is understandable. Acrete does not monetize through one undifferentiated construction bucket. The platform combines recurring factory output, technical services, engineered outputs, and, in the bridge case, selected development and project monetization layered on top of the plant.

The key interpretive point is that the factory remains the recurring earnings floor and the quality-control anchor. Development activity broadens monetization pathways and creates optionality, but it should not be allowed to blur the underlying economics of the factory node.

The corrected bridge-case financial profile is intentionally front-end burdened: startup cost and development preparation create negative EBITDA in the launch year, followed by operating leverage as revenue scales and margin improves. That profile is institutionally healthier than a model that assumes immediate premium-margin performance at launch.

The most useful investor read is not the single-year headline. It is the shape of conversion: negative launch-year margin, positive EBITDA by the operating ramp, stronger cash conversion as mix improves, and a more substantial earnings engine by 2035.

Exhibit 1. Revenue, EBITDA, and EBITDA Margin (2026–2035).

Operationally, the corrected workbook still roots into one TCI factory, but the case is no longer a pure single-product ramp. Saleable cubic yards and panel units track together, and the dual-metric ramp highlights underlying recurring revenue, and it demonstrates that development monetization is being layered onto a real operating spine rather than into a standalone project company.

Exhibit 2. Factory Output Ramp: saleable cubic yards and panel units.

The plant matters because it provides volume, quality control, proof-pack credibility, and a physical operating spine that later development activity can tap. The development overlay may change over time, but the factory will always determine whether the platform is commercially real.

The balance-sheet question is not simply whether EBITDA turns positive. It is whether the company converts operating progress into durable liquidity while maintaining enough reserve capacity to survive interruption cycles.

Acrete carries modest project-level debt and light operating leverage. There is no large platform debt, there is no complex development activity, and there is no large platform debt. Reserve build tempos tied to post-payback net income ensure the reserve line becomes consequential before expansion capital is considered.

The return structure mirrors investor-digester: investors obtain 100% preferred and the greater of the preferred hurdle or a 20%+ carried interest structure (subject to confirmed terms), above a structurally clean residual split. That shift is not cosmetic. It determines whether the continue case captures meaningful long-run economics for all parties.

Exhibit 3. Cumulative distributions and investor payback.

Capital recovery begins meaningfully in 2029 and becomes more back-end rich thereafter, which is why this raise should be described as a bridge case rather than a narrow proof memo.

The case is not risk-free, and the downside variables should remain visible. The first downside is timing and conversion, not technology or demand. Investors should interpret the risk profile through the lens of execution discipline, noting that integration logic is already designed into the system.

Governance should reinforce controllability rather than add bureaucracy. The diligence focus should remain on quality systems, staffing, inventory, equipment readiness, and reserved-matter discipline.

Investors should not read Phase 1 in isolation from the broader five-country sequence, but they also should not give later-phase optionality credit that the current phase has not yet earned.

The strongest reading of Phase 1 is that it is a disciplined first-node investment with visible, monetizable manufacturing evidence, improving operating quality, and institutional controls built to make the business financeable rather than merely interesting.

The 17+5 bridge case should be presented as a disciplined expansion of the same governed platform, not as a different company. It remains proof-first, five-country disciplined, and factory-anchored. What changes is the amplitude of Phase 1, and with it the investor's exposure to more early strategic optionality, and a stronger bridge to replication.